Related by context. All words. (Click for frequent words.) 71 Guidelines 61 guideline 56 Guidance Document 56 Position Statement 55 Recommendation 55 Clinical Practice Guideline 55 Consensus Statement 53 Continuous Disclosure 53 Final Appraisal Determination 53 Practice Guideline 52 Regulations Governing 52 § #B#.# [002] 52 Issues Relating 52 Guidelines WCAG 52 USSG § #B#.# [002] 52 Sentencing Guidelines Manual 52 CFR § #.# [007] 52 MISRA C + 52 USSG § #D#.# 51 Practice Guidelines 51 CICA Accounting Guideline 51 AS NZS #:# 51 GRI G3 51 Proposed Rule 51 Clinical Guideline 51 Practice Direction 51 Specification PAS 51 CEQA Guidelines 51 Proposed Regulations 51 § #-#-# [002] 51 PhRMA Code 51 CFR #.# d 50 Regulations 50 Methodology 50 § #D#.# 50 Clinical Practice Guidelines 50 Randomized Controlled Trials 50 #B#.# 50 Policy Statement 50 Voluntary Guidelines 50 NJSA #:#-#.# [001] 50 Agency Prohibited List 50 Guideline Update 50 Program NCEP 50 GRI Guidelines 49 Appropriateness Criteria 49 § #G#.# 49 NJSA #:# C 49 Hazardous Waste Regulations 49 Prohibited List 49 Consultation Paper 49 CFR § #.# [003] 49 La.Code Crim.P. art 49 Section #B#.# 49 Rev. Proc 49 Appendix VII 49 Consultation Document 49 Recommended Practices 49 Disclosure Requirements 49 Pa.CS § 49 Regulatory Regime 49 Pa.RAP 49 Ark. Sup 49 Revised Guidelines 49 Best Practice Guidelines 49 CP#/# 49 Discussion Paper 48 END FOOTNOTE 48 CFR § #.# [006] 48 CSR #-#.# 48 CFR § #.# [008] 48 Product Characteristics SmPC 48 Administrative Procedure 48 Analytical Methods 48 Framework Directive 48 Proposed Revisions 48 § #C#.# 48 CFR § #.# [002] 48 Ordinance Cap. 48 USSG § 48 CFR #.# c 48 Counterparty Criteria 48 Arterial Hypertension 48 #.#-# [005] 48 Core Principles 48 ACC AHA ESC 48 Amending Directive 48 Exposure Draft 48 Stable Angina 48 RCW #.#A.# 48 Code § #.#-# [001] 48 Web Content Accessibility 48 Directive #/#/EC [004] 48 AS NZS #.# 48 Regulatory Framework 48 Corporate Governance Principles 48 Generally Accepted 48 USSG § #G#.# 48 Specification 48 NJSA 2A #A 48 guidelines 48 HKAS 48 § #.# [002] 48 La.RS #:# [001] 48 #K#.# 48 CFR § #.# [001] 48 Periodic Review 48 Operational Guidelines 48 Horizontal Merger Guidelines 48 Main Outcome Measure 48 § § #-#-# [001] 47 Ethical Considerations 47 § #-# [004] 47 Surviving Sepsis Campaign 47 Position Paper 47 Sentencing Reform Act 47 § #K#.# b 47 FSP FAS #-# 47 NCGS § 47 Investigational Drugs 47 #/#/EEC [002] 47 Recommended Practice 47 ACAS Code 47 Screening Tool 47 USSG § #D#.# b 47 Privacy Principles 47 Presentence Report 47 CFR #.# [002] 47 CICA Handbook 47 Accounting Standards Codification 47 ADAAG 47 Essential Requirements 47 Policy Framework 47 Differential Diagnosis 47 ICH E# 47 Accounting Pronouncements 47 Capital Adequacy Framework 47 #.#-# [006] 47 Diseases ICD 47 G3 Guidelines 47 Improving Outcomes 47 Procedure 47 Provisional Regulations 47 Interpretive Guidance 47 CFR #.# b 47 Disclosure Controls 47 Supplement 47 Permanent Impairment 47 ICAO Annex 47 CHMP Opinion 47 Ministerial Decree No. 47 Remuneration Code 47 Symptom Checklist 47 Eur Urol 47 § #-#-# [004] 47 Report EIR 47 Screening Questionnaire 47 NIH Publication 47 Wyo. Stat 47 No.#/# [003] 47 AFI #-# 47 Jury Instruction 47 MB Docket 47 ACC AHA SCAI 47 § #.# [006] 47 Diagnostic Criteria 47 Conversion Factor 47 Requirement 47 Statement EIS 46 Expert Advisory Panel 46 § #.#.# [002] 46 Filing Requirements 46 Performance Benchmarks 46 Imposing Lawyer 46 O. Reg 46 Reliability Standards 46 Therapeutic Approaches 46 Loan Originator Compensation 46 Regulation 46 Checklist 46 Protective Measures 46 ILCS #/#-# [001] 46 Chronic Heart Failure 46 TCA § #-#-# [003] 46 Accessibility Guidelines 46 Content Accessibility Guidelines 46 DOSAGE AND ADMINISTRATION 46 Opioid Use 46 § #A#.# 46 ErP 46 Analytical Reasoning 46 § #A.# 46 Paragraph 46 Asbestos Regulations 46 #:# -# Abstract Free [002] 46 Ethical Guidelines 46 ASME Boiler 46 Civil Procedure Rule 46 Laryngeal Cancer 46 § #L#.# 46 Hedging Relationships 46 CFR § #.# [005] 46 Regulatory Frameworks 46 #/#/CE 46 Clin Trials 46 Percutaneous Coronary Interventions 46 Product Monograph 46 USSG § #L#.# 46 CFR § #.# [004] 46 Outcome Measures 46 TORs 46 Tennessee Code Annotated 46 Guidelines Recommend 46 Explanatory Note 46 Food Labelling 46 Colo. Sess 46 USC § #c 46 Subpart E 46 #a subdivision 46 FAR #.# 46 Regulatory Requirements 46 MRS § 46 § #a [001] 46 Analytical Method 46 Accounting Standard AASB 46 ARS § #-# [002] 46 B.1 46 Practice Recommendations 46 ACC AHA 46 Ann Emerg Med 46 subsection h 46 Penalty Guidelines 46 ABPI Code 46 Procedural Requirements 46 § #.#.# [001] 46 Disclosure Document 46 Tumor Response 46 Explanatory Notes 46 BS #:# 46 IOSCO Code 46 USSG 46 NICE guideline 46 Sentencing Guideline 46 EITF Topic D 46 NCCN Drugs 46 DFARS 46 AMA Guides 46 guidlines 46 Impact Assessments 46 Control Devices MUTCD 46 GHTF 46 NJSA #:#-# [004] 46 Process Validation 46 Ohio Adm.Code 46 FASB Accounting Standards Codification 46 Dangerous Substances 46 Discussion Document 46 USC § #A 45 Conceptual Framework 45 Study Shows Benefits 45 Customs Tariff Act 45 ANSI HI 45 Continuous Disclosure Policy 45 Revised Recommendations 45 Guidelines Issued 45 FFDCA 45 Pricing Supplement 45 Food Additives 45 ACE Inhibitor 45 NJSA 2C :5 45 Quality Initiative KDOQI 45 Colorado Revised Statutes 45 DSM IV TR 45 See TCA § 45 Proxy Disclosure 45 PCAOB Auditing Standard 45 § #-#.# [004] 45 § #A [001] 45 CFR § 45 CFR pt 45 USC § #d 45 CFR #.# [005] 45 #.#B [003] 45 prospective observational cohort 45 Rule #:#-# [002] 45 Incoterms ® 45 CICA Section 45 NJSA 2C :# 45 § #-#.# [003] 45 Enforceability 45 A.2 45 Preliminary Findings 45 Act Pub. L. 45 ANSI NSF 45 Directive #/#/EEC [001] 45 Procedural Rules 45 FASB Emerging 45 SEBI Delisting 45 Predictive Toxicology 45 Reevaluation 45 Compliance Requirements 45 EC Directive 45 Suppl. 45 Procedure Code 45 Spinal Manipulation 45 CFR #.# [001] 45 § #.#-# [004] 45 Disclosure Interpretations 45 Accounting Guideline 45 Regulatory Toxicology 45 Arch Dermatol 45 RC #.# F 45 USC #a [001] 45 DC Code § 45 Psychiatric Epidemiology 45 CVM Instruction 45 Sentencing Guidelines USSG 45 SFAS No.# 45 Loss Ratios 45 Policies Procedures 45 ANSI AAMI 45 B.2 45 AS#.# 45 FATF Recommendations 45 Recent Accounting Pronouncements 45 Sodium Intake 45 Va. Code § 45 Selection Criteria 45 Listing Rule #.#.# [003] 45 CFR #.# [007] 45 OCGA § #-#-# [002] 45 Hr'g Tr 45 NJSA #A :# 45 Liver Fibrosis 45 Bimonthly 45 s.# [001] 45 Antiretroviral Drug 45 Enabling Clause 45 Arbitration Agreements 45 Practitioner Guide 45 Listing Requirements 45 Package Insert 45 USC § #u 45 Taxonomies 45 Standards GIPS 45 Statement 45 List EDL 45 Disruptive Behavior 45 KRS #A.# [002] 45 Pharmacopoeia USP 45 MHPAEA 45 Chronic Lyme Disease 45 CPSS IOSCO 45 Task Force EITF 45 Initiative K DOQI 45 Recommendations 45 Appendix 45 Performance Standards GIPS 45 Pesticide Residues 45 FASB ASC #-# 45 NJAC #:#-#.# 45 NAICS code # 45 IFRSs 45 e# e# [003] 45 ACCME Standards 45 Edinburgh Postnatal Depression 45 § #A [002] 45 See id 45 Supplementary Prospectus 44 Handling Rules 44 Breast Density 44 Endocrine Disruptors 44 Contraceptive Use 44 #A#.# 44 Therapeutic Intervention 44 Pressure Vessel Code 44 Supp. 44 Directive #/#/EC [001] 44 International Statistical Classification 44 substantively reasonable 44 Evaluation Process 44 Biological Effects 44 SAMREC 44 Section #.# [001] 44 Preconception 44 ASTM F# [001] 44 Subsection b 44 § #-#.# [001] 44 #:# [013] 44 FASB Interpretation 44 COSHH 44 Repl. 44 Vapor Intrusion 44 Interagency Guidance 44 Disciplinary Procedures 44 #.#-# [020] 44 WADA Prohibited List 44 Directives 44 USC § #b [002] 44 section #.#.# 44 Standard #.#-# 44 Permitted Uses 44 Guiding Principles 44 Ministerial Decree 44 FASB Statement 44 #:#-# [002] 44 PDSs 44 EC Directives 44 Formularies 44 Batas Pambansa Blg 44 EIA Notification 44 ICH GCP 44 Sentencing Guidelines 44 Framework 44 Requirements 44 REACH SVHC 44 Reporting Requirements 44 Platelet Function 44 Use Disorders 44 Carotid Artery Stenting 44 Detection Evaluation 44 Unapproved Drugs 44 Foodstuffs Cosmetics 44 Corporate Governance Code 44 #.#-# b [001] 44 Headache Disorders 44 Proposed Rule Changes 44 Hazardous Materials Regulations 44 WAC #-#-# 44 Code § #-# [001] 44 Ensure Compliance 44 Rev. Rul 44 Substantiation 44 Standardized Distributable Cash 44 #:# -# Abstract Free [001] 44 Breach Notification 44 Revised Guidance 44 ANPRM 44 #CFR 44 Homosexual Persons 44 Criminal Procedure Law 44 Acceptability 44 Florida Statute #.# [002] 44 ASHRAE Standard 44 HRS § #-# [001] 44 CFR #.# [008] 44 Code Sec 44 Article 44 Publicly Available 44 Blakes Bulletin 44 Practical Guidance 44 § #A b 44 Section #-#-# [005] 44 Proposed Changes 44 RSA #:# [001] 44 NCAA Bylaw #.#.# 44 #-#-#.# [002] 44 Corporate Governance Policies 44 Notice #-# [001] 44 § #-#-# [003] 44 Psychiatric Diagnosis 44 MISRA 44 Pa.CSA § 44 ICH guidelines 44 Section #-#-# [004] 44 Treating Chronic 44 Guidance 44 Structured Finance Transactions 44 Code 44 Combating Counterfeit Drugs 44 Eligibility Requirements 44 GS1 EPCglobal 44 Consultation Conclusions 44 SmPC 44 See Restatement Second 44 TRIPs Agreement 44 Accounting Standards Codification Topic 44 Evid.R. 44 DSM IV diagnoses 44 directive #/#/EC [002] 44 Urgent Issues 44 Psychotropic Drugs 44 Board GASB 44 OFPA 44 Systematic Review 44 Indoor Radon 44 Brief Description 44 subsection c 44 Acute Kidney 44 § #a [002] 44 RISDP 44 Common Pitfalls 44 Subsection c 44 General Accepted Accounting 44 Evidentiary 44 Appendix B 44 Decree #/#/ND-CP [002] 44 NJSA 2C :2 44 #/#/EEC [001] 44 #/#/EC [002] 44 Diagnostic Radiopharmaceuticals 44 Breast Exams 44 Directive #/#/EC [005] 44 USC § #f 44 Acne Drug 44 Applicable Criteria 44 FAR Subpart 44 Minimisation 44 § #L#.# b 44 Legal Practitioners Act 44 Air Pollutants 44 § #.#-# [002] 44 Scoping Plan 44 Langes + 44 Cases Involving 44 Risk Assessment 44 Ophthalmic Drug 44 Assessment Framework 44 Test Methodology 44 Evaluation Tool 44 Operational Procedures 44 #/#/EC [001] 44 IEC EN # 44 Uniform Standards 44 Medication Adherence 44 NCCN Drugs & 44 Administrative Code § 44 MSRB Rule G 44 Disciplinary Actions 44 Pregnancy Outcomes 43 Stipulated Order 43 Diagnostic Statistical Manual 43 Strategic Framework 43 Combustible Dust 43 Blood Cholesterol 43 Jury Instructions 43 VBER 43 Phytosanitary Measures 43 Clinical Outcome 43 SADC Protocol 43 Task Force USPSTF 43 Basel Accord 43 Medication Errors 43 Blood Pressure Medication 43 IC § #-# 43 Tort Liability Law 43 e# e# [001] 43 Product Characteristics 43 Acceptance Criteria 43 Directive #.# 43 NJSA #:#-# [002] 43 SORP 43 Ecodesign Directive 43 Conforms 43 R. #:#-# 43 Mineral Reserves Best Practices 43 Reasonable Accommodation 43 Pa. Code § 43 Carotid Endarterectomy 43 RC #.# B [001] 43 Reduces Mortality 43 Main Outcome Measures 43 Surgical Techniques 43 CICA Emerging 43 Musculo Skeletal Disorders 43 #:#-#,# CrossRef Medline [002] 43 Supplementary Appendix 43 #:#-# Abstract Free [003] 43 C.1 43 MCL #.# [001] 43 Depressive Symptoms 43 LSA RS #:# [002] 43 Mortality Risk 43 USSG § #B#.# [001] 43 #-#.# [014] 43 Compliance Statement 43 Pluripotent Stem Cells 43 OCGA § #-#-# [006] 43 § #E#.# 43 FSP AUG AIR 43 Biochemical Pharmacology 43 #.#.#.#.#.# 43 Mammographic 43 APB Opinion No. 43 Biologics Compendium 43 Eur J Cancer 43 EORTC QLQ C# 43 See ARS § 43 SUPPLEMENTARY INFORMATION 43 Hotly Debated 43 Conclusions 43 Aplt 43 Diseases Ninth 43 IVSC 43 #:#-#,# Abstract Free 43 Psychological Effects 43 Directive 43 Constraint 43 Motorized Travel 43 Acquisition Regulation FAR 43 updated NCCN Guidelines 43 Subparagraph 43 Nonpoint Source 43 Original Bidder Statement 43 Child Mortality 43 DFARS #.#-# 43 Methodological 43 Vertical Restraints 43 Combo Therapy 43 Interoperability Standards 43 Evidenced Based 43 Exercise Induced Asthma 43 § #-#-# [008] 43 CALCRIM Nos. 43 USPSTF recommends 43 Council Directive #/#/EEC 43 Nocturia 43 NASD Rule 43 ARS § 43 § #:# [001] 43 Am J Epidemiol 43 Proposed Arrangement 43 Auditing Standard 43 Recalculation 43 #.# subdivision [004] 43 Directive #/#/EEC [002] 43 Classification System 43 Mitigated Negative Declaration 43 Corrective Action Plan 43 Genetic Tests 43 Determinations 43 Atomoxetine 43 WASPA Code 43 Double Taxation Agreements 43 Cognitive Function 43 OSC Policy 43 Standardized Approach 43 para. 43 section #.# subdivision 43 Procurement Regulations 43 CRZ Notification 43 SYSC 43 Section #-#-# [007] 43 Clause #.#.# 43 Practical Implications 43 EPDS 43 Auditing Standards 43 UNCITRAL Model Law 43 Illness Prevention 43 USSG § #K#.# b 43 SADC Principles 43 C.3 43 #A.# [005] 43 § #:# [002] 43 theAmerican Journal 43 Selection Procedures 43 Adjudicatory 43 Regulatory Impact Statement 43 Personnel Policies 43 FINA Doping 43 DCID 6 43 Cardiac Marker 43 Colorectal Screening 43 Mentally Ill Offender 43 #B.# [002] 43 Cognitive Impairment 43 ACCF AHA 43 Procurement Procedures 43 Financial Institutions Examinations 43 Directive #/#/EU 43 Disorders Identification 43 Self Assessment Tool 43 Thematic Strategy 43 Oral Fluid 43 Procurement Guidelines 43 Transatlantic Agenda 43 Clinical Significance 43 WAIS III 43 Simplified Acquisition 43 Continued Airworthiness 43 BMC Musculoskeletal Disorders 43 Systematic Approach 43 Tailoring Rule 43 CALCRIM 43 Listing Rule #.#A 43 Flammability 43 MBTOC 43 Income Tax Regs 43 p rior 43 Commission Decision #/#/EC 43 Sentencing Guidelines Manual USSG 43 Protein Synthesis 43 Factsheet 43 Vaginal Birth After 43 Subtypes 43 #.# subd [004] 43 Interpretative Communication 43 Consensus Forecasts 43 Board FASB Accounting 43 EU Directive #/#/EC 43 Trans Fat Task Force 43 Prescription Painkiller 43 § #.# [001] 43 Rating Methodology 43 Implementation Guides 43 Hazardous Substances RoHS Directive 43 COSO framework 43 #:#-# Abstract Free [001] 43 Reduction Strategy 43 Fitch AAAmmf rating 43 Fed.R.Civ.P. 43 Evid 43 Circular Letter 43 Asthma Treatment 43 Occupational Exposure 43 Addendum 43 Psychodynamic Psychotherapy 43 Practical Application 43 DFAR 43 Childhood Trauma 43 Majority Voting 43 NCCN Guidelines 43 Pandemic Influenza Vaccines 43 Nondiscrimination 43 Legal #.# 43 Control Objectives 43 Index CEPI 43 OSHA #.# 43 Cervical Spine 43 WpUG 43 Monograph 43 Psychiatric Disorders 43 Therapy Reduces 43 Technical Specifications 43 Stocktaking 43 #:#-# [019] 43 Capability Model 43 doi Abstract Free 43 Minimum Standards 43 Postmarket 43 Practical Aspects 43 :5 43 See USSG § #B#.# 43 document A/#/# [002] 43 Instrument #-# 43 NGER Act 43 DR #-# 43 Strategic Approach 43 DOI #.#/j.#-#.#.#.x 43 Trans Fatty Acids 43 RC #.# B [002] 43 Solicitation Number 43 Kidney Disease Outcomes 43 § #K#.# 43 Curriculum Framework 43 Standardised 43 FINRA Rule 43 Exposure Drafts 43 Dietary Ingredients 43 Makes Recommendations 43 AFEP MEDEF recommendations 43 Money Laundering Regulations 43 Licence Agreements 43 W3C HTML 43 Audience Metrics 43 subparagraph b 43 Antidepressant Treatment 43 SCENIHR 42 Biosurveillance 42 #-# Full Text 42 Comprehensive Approach 42 Osteoarthritis Pain 42 Statistical Tables 42 Uniform Rules 42 Sliding Scale 42 FASB ASC Topic 42 MedDRA 42 Hormonal Therapy 42 COBIT Control 42 Wis. Stat 42 #.# subdivision [001] 42 Substances Hazardous 42 Pharmacologic Treatment 42 LSA RS #:# [001] 42 Section #-#-# [006] 42 NCCN Updates 42 Approval Process 42 CFR § § #.# [002] 42 L.#/# 42 #:#-# Abstract Free [010] 42 Work SOW 42 Coronary Disease 42 1.a. 42 CIM Best Practices 42 Systemically Important 42 Comorbidities 42 § #G#.# b 42 #.#-# [016] 42 Listing Rule #.#.# [005] 42 Informed Choices 42 Approvable 42 Procedures Manual 42 Social Networking Websites 42 PMBOK ® Guide 42 Section #.#.# [001] 42 SEC Rule #b 42 AECA 42 #:#-#,# [002] 42 cmt 42 Miscellaneous Provisions 42 § #B#.# [001] 42 § #A [003] 42 Drivers Licence 42 ToRs 42 COMELEC Resolution 42 Solvency II Directive 42 Okla. Stat 42 NIHSS score 42 Remedies Directive 42 Hedging Relationships AcG 42 Rating Guidelines 42 Inflammatory Pain 42 Source Langes + 42 Protection ICNIRP 42 Subsidiary Arrangements 42 suppl. 42 Establishment Inspection 42 § 7B 42 Monetary Penalties 42 Monthly Newsletter 42 PELs 42 DMEPOS supplier 42 Treatment Regimen 42 ISO IEC #-# [001] 42 K DOQI 42 Minimum Continuing 42 Circular 42 Quality Indicators 42 TLVs 42 Doha Ministerial Declaration 42 Functioning Disability 42 Directive #/#/EC [002] 42 Cesarean Delivery 42 Regulatory Developments 42 WCAG 42 § #-#.# [002] 42 KRS #.#-# 42 Levels Linked 42 Wound Closure 42 Dangerousness 42 Criminal Procedural Law 42 IETF RFC 42 Transparency Obligations Directive 42 Risk Assessment Tool 42 Sentencing Advisory Panel 42 Gene Variation 42 #:#-# Abstract Free [002] 42 Tumor Markers 42 NJSA #:#-#.# [003] 42 Packaging Waste 42 RSMo 42 Governance Structure 42 Drug Regimen 42 Suicidal Behavior 42 Legal Considerations 42 Accounting Standards IAS 42 2C :# 42 Antidumping Duties 42 Corrective Actions 42 Screening Mammography 42 section #.# 42 Pupil Accommodation Review 42 Childhood Vaccinations 42 Presentence Investigation Report 42 Accessibility Initiative WAI 42 Add.1 42 Accounting Policies 42 MFDA Rules #.#.# 42 Auditing Practices Board 42 Rule #-#.# 42 #:#-# Abstract Free [004] 42 Suboptimal 42 Competitive Analysis 42 Bioequivalence 42 :9 42 PS § 42 Amendment Bylaw 42 Greystar Resources Announces 42 Notified Bodies 42 Susceptibility Testing 42 CFR Parts 42 HSW Act 42 Code § #.# [002] 42 Reply Brief 42 KDOQI 42 Scheduling Order 42 OGC OpenGIS 42 Paragraphs 42 Hormone Replacement 42 Categorization 42 Subscale 42 Submittals 42 Reveals Significant 42 Financial Reporting Interpretations 42 s#A [001] 42 Cumulative Effects 42 Survey MEPS 42 Preterm Delivery 42 Compulsory Purchase Act 42 EU directive #/#/EC 42 Donor Organs 42 Strategy 42 Sustained Release 42 FAS# R 42 Substances Act CDSA 42 ORS #A.# 42 Fee Schedule 42 Disclosure Requirement 42 Slip Op 42 Determination Letter 42 p.# [001] 42 SHIRE PLC 42 TB Vaccine 42 Randomized Clinical Trials 42 Mitigation Strategy 42 Basic Principles 42 Bidding Documents 42 #:#-# [037] 42 Candidate Recommendation 42 Population Projections 42 Dietary Reference Intakes 42 Outpatient Setting 42 Supplementary PDS 42 FAR #.#-# Instructions 42 AICPA Statement 42 Harmonization Task Force 42 Zoning Bylaw 42 Directive #/#/EC [006] 42 IRCP 42 Drug Utilization 42 NTER 42 Practical Steps 42 Determinations Panel 42 Rules 42 Adverse Effects 42 Breast Carcinoma 42 #:#-# Abstract Free [009] 42 SEC Regulation SX 42 Clinically Tested 42 #.# subdivision [003] 42 Statutory Accounting Principles 42 Study Reinforces 42 relation thereto 42 KDOQI guidelines 42 Advisers Act 42 USSG § #D#.# c 42 Regulation Supplement DFARS 42 USSG § #A#.# 42 Psychiatric Illness 42 EPBD 42 Logical Reasoning 42 Total Coliform Rule 42 EIA Environmental Impact 42 Applicable criteria 42 PM#.# NAAQS 42 USC § #a [001] 42 ASTM Standards 42 § #.# [004] 42 Allowable 42 Annex VI 42 FASB Codification 42 SFAS# 42 Pub. 42 Hazardous Drugs 42 Clinical Modification 42 Gen. Stat 42 Circulars 42 § #-#-#.# 42 Complies 42 Macroprudential 42 § #-#-# [006] 42 Contracts Regulations 42 Mortgage Arrears 42 Balanced Approach 42 SF #v# 42 Preventive Measures 42 Uniform Dispute Resolution 42 KAR #:# 42 NACI 42 GASB Issues 42 Environmental Impacts 42 Review Mechanism 42 DIN ISO 42 FAR clauses 42 Performance Measurement 42 Asthma Medication 42 La.RS #:#.# [002] 42 Certifi cate 42 Easily Accessible